- Trials with a EudraCT protocol (57)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
57 result(s) found for: Carbon 13.
Displaying page 1 of 3.
EudraCT Number: 2007-003250-29 | Sponsor Protocol Number: IPAB-07-002 | Start Date*: 2008-03-14 | |||||||||||
Sponsor Name:Independent Pharmaceutica AB | |||||||||||||
Full Title: A randomised, placebo-controlled, multi-centre study on the efficacy of Niccine, a vaccine for nicotine, in smoking relapse prevention, assessed in abstinent, adult smokers. | |||||||||||||
Medical condition: The intended indication for the drug under investigation is smoking relapse prevention. Tobacco smoking has been identified as the single largest preventable cause of morbidity and premature death ... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016489-10 | Sponsor Protocol Number: TPF-C-HIT | Start Date*: 2010-08-23 |
Sponsor Name:University of Heidelberg | ||
Full Title: Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanc... | ||
Medical condition: The study is a phase II study of induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) followed by radioimmunotherapy with Cetuximab and intensity modulated radiotherapy (IMRT... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000138-11 | Sponsor Protocol Number: PIPF-006 | Start Date*: 2006-05-23 |
Sponsor Name:InterMune, Inc. | ||
Full Title: A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Study of the Safety and Efficacy of Pirfenidone in Patients with Idiophatic Pulmonary Fibrosis | ||
Medical condition: Idiophatic Pulmonary Fibrosis (IPF) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) DE (Completed) BE (Completed) CZ (Prematurely Ended) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003158-18 | Sponsor Protocol Number: 203PF203 | Start Date*: 2018-09-12 | |||||||||||
Sponsor Name:Biogen Idec Research Limited | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of BG00011 in Patients With Idiopathic Pulmonary Fibrosis | |||||||||||||
Medical condition: mild to moderate Idiopathic Pulmonary Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) GB (Prematurely Ended) DK (Prematurely Ended) NL (Prematurely Ended) GR (Completed) BE (Completed) ES (Prematurely Ended) DE (Prematurely Ended) PL (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005125-12 | Sponsor Protocol Number: LIRALUNG | Start Date*: 2016-05-12 |
Sponsor Name:Dr. Albert Lecube, Ph.D., M.D. | ||
Full Title: MULTICENTRE RANDOMIZED DOUBLE BLIND, CROSSOVER, PLACEBO-CONTROLLED CLINICAL TRIAL TO EVALUATE THE EFFECT OF LIRAGLUTIDE ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (LIRALUNG STUDY) | ||
Medical condition: Type 2 Diabetes | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000064-24 | Sponsor Protocol Number: AB2012-UBT01 | Start Date*: 2012-07-12 | |||||||||||
Sponsor Name:AB ANALITICA SRL | |||||||||||||
Full Title: Comparative assessment of diagnostic performance of C13-Urea Breath Test (BREATHQUALITY-UBT, oral solution C13-Urea 75 mg/10 mL) with 10 min protocol vs standard 30 min protocol to determinate the ... | |||||||||||||
Medical condition: Presence of symptoms referable to the proximal segment of the digestive system, indicative of a possible Helicobacter pylori infection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000791-38 | Sponsor Protocol Number: WA42293 | Start Date*: 2021-04-14 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS | |||||||||||||
Medical condition: Idiopathic pulmonary fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) CZ (Completed) DE (Completed) HU (Completed) GR (Prematurely Ended) FI (Completed) PT (Prematurely Ended) NO (Completed) DK (Prematurely Ended) PL (Completed) NL (Completed) BE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004025-40 | Sponsor Protocol Number: PA101-CC-02 | Start Date*: 2015-02-06 | |||||||||||
Sponsor Name:Patara Pharma | |||||||||||||
Full Title: Treatment of Chronic Idiopathic Cough (CIC) and Chronic Cough in patients with Idiopathic Pulmonary Fibrosis (IPF) with PA101. | |||||||||||||
Medical condition: Chronic Idiopathic Cough and Chronic Cough in Idiopathic Pulmonary Fibrosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000381-11 | Sponsor Protocol Number: CCMK389X2201 | Start Date*: 2020-06-16 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A subject and investigator blinded, randomized, placebo-controlled, repeat-dose, multicenter study to investigate efficacy, safety, and tolerability of CMK389 in patients with chronic pulmonary sar... | |||||||||||||
Medical condition: Chronic pulmonary sarcoidosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) DK (Completed) CZ (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001429-30 | Sponsor Protocol Number: WA42294 | Start Date*: 2021-03-15 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE III OPEN-LABEL EXTENSION STUDY TO EVALUATE LONG-TERM SAFETY AND EFFICACY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) | |||||||||||||
Medical condition: Idiopathic pulmonary fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) CZ (Completed) DE (Prematurely Ended) SE (Prematurely Ended) GR (Prematurely Ended) HU (Completed) PT (Prematurely Ended) AT (Prematurely Ended) FI (Completed) NO (Completed) DK (Prematurely Ended) PL (Completed) NL (Completed) BE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002500-91 | Sponsor Protocol Number: RPC01-3001 | Start Date*: 2015-10-12 | |||||||||||
Sponsor Name:Celgene International II Sàrl (CIS II) | |||||||||||||
Full Title: A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis | |||||||||||||
Medical condition: Relapsing Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) BE (Completed) GB (Completed) ES (Completed) BG (Completed) SK (Completed) GR (Completed) PL (Completed) LV (Completed) EE (Completed) LT (Completed) PT (Completed) SE (Completed) HR (Completed) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004157-41 | Sponsor Protocol Number: GLPG1690CL202 | Start Date*: 2016-03-21 | |||||||||||
Sponsor Name:Galapagos NV | |||||||||||||
Full Title: Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter, Exploratory Phase IIa Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 Adm... | |||||||||||||
Medical condition: Idiopathic pulmonary fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003473-17 | Sponsor Protocol Number: CC-90001-IPF-001 | Start Date*: 2017-09-14 | |||||||||||
Sponsor Name:Celgene Corporation | |||||||||||||
Full Title: A Phase 2, 24-Week Randomized, Double-blind, Placebo-Controlled Multicenter Study, With an 80-Week Active Treatment Extension, to Evaluate the Efficacy and Safety of CC-90001 in Subjects with Idiop... | |||||||||||||
Medical condition: IDIOPATHIC PULMONARY FIBROSIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) GR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005592-13 | Sponsor Protocol Number: FERRICHFII | Start Date*: 2014-02-27 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Mechanisms of Exercise Benefit with Intravenous Iron in Chronic Heart Failure: The Ferric Iron in Heart Failure (FERRIC HF) II Trial | |||||||||||||
Medical condition: Chronic Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000605-24 | Sponsor Protocol Number: ESPERANZA_COVID | Start Date*: 2021-07-08 | |||||||||||
Sponsor Name:IDIAP Jordi Gol | |||||||||||||
Full Title: Double-blind Randomized Clinical Trial, Placebo-controlled to Assess the Efficacy of Montelukast in Mild-moderate Respiratory Symptoms in Patients With Long-COVID: E-SPERANZA COVID PROJECT | |||||||||||||
Medical condition: Patients with a history of SAR-Cov-2 infection (PCR positive) with long Covid-19 and mild or moderate respiratory symptoms of more than 1 month and less than 4 months of evolution, attended in Prim... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003237-41 | Sponsor Protocol Number: MK-7339-012 | Start Date*: 2020-06-23 | |||||||||||
Sponsor Name:Merck Sharp & Dohme LLC | |||||||||||||
Full Title: A Phase 3 Study of Pembrolizumab (MK-3475) in Combination with Concurrent Chemoradiation Therapy Followed by Pembrolizumab with or without Olaparib vs Concurrent Chemoradiation Therapy Followed by ... | |||||||||||||
Medical condition: unresectable, locally advanced, Stage III Non-Small Cell Lung Cancer (NSCLC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Trial now transitioned) HU (Ongoing) LV (Ongoing) DE (Ongoing) PL (Trial now transitioned) EE (Ongoing) FR (Ongoing) GB (GB - no longer in EU/EEA) RO (Ongoing) IT (Ongoing) LT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004719-10 | Sponsor Protocol Number: AC-058B303 | Start Date*: 2017-10-02 | ||||||||||||||||
Sponsor Name:Actelion Pharmaceuticals Ltd. | ||||||||||||||||||
Full Title: Multicenter, non-comparative extension to study AC-058B301, to investigate the long-term safety, tolerability, and control of disease of ponesimod 20 mg in subjects with relapsing multiple sclerosis | ||||||||||||||||||
Medical condition: relapsing multiple sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) SE (Completed) PL (Completed) CZ (Completed) BG (Completed) LV (Completed) HU (Completed) LT (Completed) PT (Ongoing) HR (Ongoing) GB (GB - no longer in EU/EEA) FI (Completed) GR (Completed) RO (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001870-38 | Sponsor Protocol Number: GTi1201 | Start Date*: 2014-01-09 | |||||||||||
Sponsor Name:Grifols Therapeutics Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Two Dose Regimens (60 mg/kg and 120 mg/kg) of Weekly Intravenous Alphal-Proteinase Inhibitor (Human) in Sub... | |||||||||||||
Medical condition: Pulmonary Emphysema due to Alpha-1-Antitrypsin Deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) IE (Completed) EE (Completed) DK (Ongoing) ES (Completed) FI (Restarted) PL (Ongoing) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000252-41 | Sponsor Protocol Number: PIPF-004 | Start Date*: 2006-06-29 | |||||||||||
Sponsor Name:InterMune, Inc. | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled, Phase 3 Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis | |||||||||||||
Medical condition: Idiopathic Pulmonary Fibrosis (IPF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003551-32 | Sponsor Protocol Number: ISS-U1111-1188-8695 | Start Date*: 2017-11-01 | |||||||||||
Sponsor Name:Hospital of South West Jutland | |||||||||||||
Full Title: Effects of GLP-1 receptor agonist treatment on pulmonary function and quality of life in obese patients with chronic obstructive pulmonary disease - A prospective, randomized, placebo-controlled, ... | |||||||||||||
Medical condition: Chronic obstructive pulmonary disease in obese subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.